HLA shared epitope is linked to both the risk of developing RA and the risk of having ACPA-positive RA, but not to the risk of having ACPA alone [59], which indicates its role in both ACPA production and the effector phase of arthritis. This evidence concerns the gene PRTN3 and rheumatoid arthritis.